Modulating Systemic Immune-Inflammatory Indices via Double Filtration Plasmapheresis: Implications for Aging and Low-Grade Inflammation

Abstract

Systemic immune-inflammatory indices derived from routine complete blood counts are useful markers of systemic inflammation across various conditions. Currently, double filtration plasmapheresis is used to lower lipid levels and remove pro-inflammatory mediators; however, its effects on systemic immune-inflammatory indices are underreported. A retrospective analysis of patients undergoing two double filtration plasmapheresis sessions for hypercholesterolemia or hyperlipoproteinemia(a) at a single center was conducted between April and July 2025. Complete blood count-derived immune-inflammatory indices and lipid profiles were measured immediately before and after the first and second double filtration plasmapheresis sessions, respectively. Intra-individual comparisons were performed using the Wilcoxon signed-rank test. Double filtration plasmapheresis performed with the Inuspheresis System significantly reduced the neutrophil-to-lymphocyte ratio (p=0.040), platelet-to-lymphocyte ratio (p=<0.001), systemic immune-inflammatory index (p=0.008), and aggregate index of systemic inflammation (p=0.048), while significantly increasing lymphocyte-to-monocyte ratio (p=<0.001); systemic inflammation response index did not change significantly. Expected reductions were also observed in total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and lipoprotein(a), all with p <0.001. In addition to its lipid-lowering effects, double filtration plasmapheresis modulated short-term systemic immune-inflammatory indices, indicating potential utility for these metrics as surrogate markers of acute systemic inflammation and immunomodulation. Given their availability from routine complete blood counts, monitoring these indices could aid individualized patient assessment during double filtration plasmapheresis. These results may also help refine personalized care in patients with low-grade inflammation and aging-related immune dysfunction.

Keywords

aging - hypercholesterolemia - immunomodulation - inflammation mediators - plasmapheresis - hyperlipoproteinemia

Publikationsverlauf

Eingereicht: 16. Juli 2025

Angenommen nach Revision: 30. September 2025

Artikel online veröffentlicht:
14. November 2025

• References

• 1 Budzianowski J, Pieszko K, Burchardt P. et al. The role of hematological indices in patients with acute coronary syndrome. Dis Markers 2017; 2017: 3041565
• 2 Pantea M, Iacob D, Dima M. et al. Predictive value of inflammatory markers NLR, PLR, APRI, SII, and liver function tests in systemic inflammatory response syndrome detection in full-term newborns. Children (Basel) 2024; 11: 593
• 3 Rajakumar HK, Coimbatore Sathyabal V, Vasanthan M. et al. The predictive role of systemic inflammation response index (SIRI), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) in the prognosis of acute coronary syndrome in a tertiary care hospital. Heliyon 2024; 10: e39029
• 4 Li Q, Ma X, Shao Q. et al. Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients. Front Cardiovasc Med 2022; 9: 811790
• 5 Hua X, Long ZQ, Huang X. et al. The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer. Curr Probl Cancer 2020; 44: 100560
• 6 Wang T, Zhang D, Tang D. et al. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2023; 149: 5627-5636
• 7 Xu Y, He H, Zang Y. et al. Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol 2022; 41: 1989-2000
• 8 Ghobadi H, Mohammadshahi J, Javaheri N. et al. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Front Med (Lausanne) 2022; 9: 916453
• 9 Guven DC, Sahin TK, Erul E. et al. The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis. Cancers (Basel) 2022; 14: 2675
• 10 Qiu S, Jiang Q, Li Y. The association between pan-immune-inflammation value and chronic obstructive pulmonary disease: data from NHANES 1999–2018. Front Physiol 2024; 15: 1440264
• 11 Moldovan F. Correlation between peripheric blood markers and surgical invasiveness during humeral shaft fracture osteosynthesis in young and middle-aged patients. Diagnostics (Basel) 2024; 14: 1112
• 12 Chen P, Liu Y, Lin X. et al. Diagnostic value of the blood neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in tibia fracture-related infection. Dis Markers 2022; 2022: 6119583
• 13 Moldovan F. Role of serum biomarkers in differentiating periprosthetic joint infections from aseptic failures after total hip arthroplasties. J Clin Med 2024; 13: 5716
• 14 Jing Y, Ren M, Li X. et al. The effect of systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) in early gastric cancer. J Inflamm Res 2024; 17: 10273-10287
• 15 Niu S, Pei Y, Hu X. et al. Relationship between the neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio and deep venous thrombosis (DVT) following femoral neck fractures in the elderly. Front Surg 2022; 9: 1001432
• 16 Vitiello R, Smimmo A, Matteini E. et al. Systemic inflammation response index (SIRI) and monocyte-to-lymphocyte ratio (MLR) are predictors of good outcomes in surgical treatment of periprosthetic joint infections of lower limbs: a single-center retrospective analysis. Healthcare (Basel) 2024; 12: 867
• 17 Qian B, Zheng Y, Jia H. et al. Neutrophil-lymphocyte ratio as a predictive marker for postoperative infectious complications: a systematic review and meta-analysis. Heliyon 2023; 9: e15586
• 18 Connelly-Smith L, Alquist CR, Aqui NA. et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue. J Clin Apher 2023; 38: 77-278
• 19 Walther R, Singh B, Yin X. et al. Proteomic profiling of age-related proteins following extracorporeal apheresis. Horm Metab Res 2025;
• 20 Yin X, Takov K, Straube R. et al Precision medicine approach for cardiometabolic risk factors in therapeutic apheresis. Horm Metab Res 2022; 54: 238-249 Corrigendum: Horm Metab Res 2022; 54: e3
• 21 Bornstein SR, Voit-Bak K, Rosenthal P. et al. Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation. Mol Psychiatry 2020; 25: 275-282
• 22 Qin R, Liu Y, Ding R. et al. Efficacy of double filtration plasmapheresis in hyperlipidemia acute pancreatitis: a retrospective observational study. Lipids Health Dis 2025; 24: 27
• 23 Sadri S, Cavusoglu G, Tunay B. Do neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience. Ther Apher Dial 2023; 27: 146-151
• 24 Hashim NA, Mohamed W, Emad E. Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study. Egypt J Neurol Psychiatr Neurosurg 2020; 56: 17
• 25 Achleitner M, Steenblock C, Dänhardt J. et al. Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry 2023; 28: 2872-2877
• 26 Straube R, Voit-Bak K, Gor A. et al Lipid profiles in lyme borreliosis: a potential role for apheresis?. Horm Metab Res 2019; 51: 326-329 Coorigendum: Horm Metab Res 2019; 51: 554
• 27 Han S, Zhang Z, Cheng S. et al. Correlations between frailty index and inflammatory markers derived from blood cell count in the United States. BMC Public Health 2024; 24: 3408
• 28 Zhang H, Hao M, Hu Z. et al. Association of immunity markers with the risk of incident frailty: the Rugao longitudinal aging study. Immun Ageing 2022; 19: 1
• 29 Zheng Z, Luo H, Xue Q. U-shaped association of systemic immune-inflammation index levels with cancer-related and all-cause mortality in middle-aged and older individuals with frailty. Arch Gerontol Geriatr 2023; 116: 105228
• 30 Tang Y, Zhai Y, Song W. et al. Association between complete blood count-derived inflammatory markers and the risk of frailty and mortality in middle-aged and older adults. Front Public Health 2024; 12: 1427546